Skip to main content

Posts

Showing posts from October, 2017

Medical Nutrition Market Predicted to Reach US$ 6,046.3 Million by the end of 2025

“ Medical Nutrition Market: Global Industry Analysis (2012-2016) and Forecast 2017–2025,” a new report by Persistence Market Research concentrates on the parenteral nutrition segment and its overall performance in the global medical nutrition market for the duration of eight years. The report segments the global parenterally administered medical nutrition market on the basis of product type, distribution channel, nutrition type and region. Global Medical Nutrition Market: Forecast by Product Type This segment is divided into Amino Acid Solution, Multiple Vitamins and Antioxidants, Lipid Emulsion, Trace Elements, 2C Bags, and 3C Bags. The Amino Acid Solution segment dominated the global parenteral medical nutrition market in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. Amino Acid Solution segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period. Browse Full Research Report...

Pneumatic Compression Therapy Market Predicted to Reach US$ 200 Million by the end of 2025

The global pneumatic compression therapy market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing adoption of pneumatic compression sleeves and pumps and a growing awareness of pneumatic compression therapy in developing economies.  A new report published by Persistence Market Research titled “Pneumatic Compression Therapy Market: Global Industry Analysis (2012 – 2016) and Forecast (2017 – 2025)” studies the overall performance of the global pneumatic compression therapy market for an eight year forecast period 2017 to 2025. The North America regional market is estimated to lead in terms of revenue generation for pneumatic compression therapy during the forecast period. Increasing patient awareness, rising disease burden and easy availability of de-addiction products through broad distribution channels are some of the factors that are expected to impact revenue growth of the global pneumatic compr...

Animal Wound Care Market Predicted to Reach US$ 13 Billion by the end of 2025

Pet humanization and increasing focus on maintaining health and well-being of animals continue to drive the growth of the animal wound care market. Changing lifestyle and increase in disposable incomes in emerging countries are also contributing to higher spending on animal healthcare. These factors are impacting the global animal wound care market, which is expected to grow at 7% CAGR through 2025. The market is projected to reach around US$ 1013 Million by the end of 2025, up from US$ 590 Million in 2017.The global animal wound care market is segmented into product type, end user and region. Browse Full Research Report: https://www.persistencemarketresearch.com/market-research/animal-wound-care-market.asp Based on product, the overall market is sub-categorized as: Advanced Wound Care Hydrogel Dressings Film Dressings Hydrocolloid Dressings Foam Dressings Traditional Wound Care Absorbents Bandages Tapes Surgical Wound Care ...

Scar Treatment Market Predicted to Reach US$ 13 Billion by the end of 2025

Persistence Market Research (PMR) delivers key insights and presents a revised forecast of the global scar treatment market for an eight year period from 2017 to 2025 in the report titled “Scar Treatment Market: Global Industry Analysis 2012–2016 and Forecast 2017–2025.” The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of key market participants. The global scar treatment market is projected to expand at a healthy CAGR of 3.9 % in terms of value during the forecast period, revised from the previous CAGR of 3.8%, due to factors regarding which PMR offers useful insights in detail in this report. Browse Full Research Report: https://www.persistencemarketresearch.com/market-research/global-scar-treatment-market-102017.asp Key Market Dynamics The prime drivers for the market include availability of att...

Intra-aortic Balloon Pump Market Predicted to Reach US$ 111 Million by the end of 2025

The  overall intra-aortic balloon pump market  is likely to be valued at nearly US$ 361 million in 2017 and is expected to account for around US$ 472 million by the end of 2027. The worldwide market is slated to exhibit 2.7% CAGR throughout 2017 to 2027.  The factors creating numerous lucrative opportunities for the worldwide market include, Growing incidences of coronary artery diseases Increased usage for the duration of cardiogenic shock Improved quality of health care Swelling partnerships Developing healthcare advancement However, the factors impeding the growth of the overall market includes Adverse events such as deaths and injuries Product recalls for concerns upon patient safety Lacking healthcare infrastructure The overall market is segmented into product type, indication, end user and region. Browse Full Research Report: https://www.persistencemarketresearch.com/market-research/intra-aortic-balloon-pump-ma...

Veterinary Anti-Infectives Market Predicted to Reach US$ 1500 Million by the end of 2025

With growing occurrence of zoonotic and food borne diseases in countries like MEA, is one of the factor influencing the demand of the attenuated live vaccines section in the region. The countries contained within the Central Europe and MEA region are highly reliant on the live stock trade as a resource of survival. Meat and milk are few of the general resources resultant of animal husbandry measures bring about in these regions. Market Segmentation The worldwide veterinary vaccines market is broadly segmented into vaccine type, disease indication, animal type, distribution channel and by country. Browse Full Research Report: https://www.persistencemarketresearch.com/market-research/veterinary-anti-infectives-market.asp Forecast by market type Based on the market type, the market is sub-segmented into inactivated vaccines, recombinant vaccines, DNA vaccines, attenuated live vaccines, toxoid vaccines and others. The attenuated live vaccines division was the b...

Animal Health Active Pharmaceutical Ingredients Market Predicted to Reach US$ 9,162.2 Million by the end of 2025

The global animal health active pharmaceutical ingredient (API) market is expected to register an impressive expansion at 7.3% CAGR during the forecast period 2017-2025. According to recent study by Persistence Market Research (PMR), it is estimated that, the revenues from animal health API market are expected to reach worth US$ 9,162.2 Mn by 2025-end. Limited Government Intervention Provides Smooth Flow to the Market Growth in APAC Asia-Pacific (APAC) will be the most lucrative region in the global animal health active pharmaceutical market, and is expected to exhibit higher CAGR by 2025-end. APAC region has been identified for housing some of the largest suppliers of affordable API. To save on the production costs, the concerned governments have been taking initiatives to compel small scale API manufacturers towards shifting their production units to APAC countries such as India and China. Limited intervention of government facilitates smoother flow of market growth in ...

U.K. Private Healthcare Market Predicted to Reach US$ 14,000 Million by the end of 2025

The decline in individual purchases of private medical insurance and low medical cover pay-outs to clinics and hospitals will continue to negatively impact the U.K. private healthcare market. Besides, the country has a well-defined public healthcare structure for its permanent residents. At the point of need, public healthcare coverage is subsidized or offered completely free and is usually paid through general taxation. Persistence Market Research in its latest study reveals that the U.K. private healthcare market is set to expand at a sluggish 2.8% CAGR during the forecast period (2017–2025). In addition, this market is anticipated to represents an absolute $ opportunity of US$ 321.4 Mn in 2018 over 2017. According to PMR findings, the U.K’s private healthcare sector is much smaller than the public sector. However, a rise in self-pay elective procedures and introduction of attractive packaged pricing is expected to support the country’s private healthcare sector in the near future....

Animal Drug Compounding Market Predicted to Reach US$ 1,373.8 Million by the end of 2024

With the decreasing number of animals over the years, the compounded drugs for animals are likely to witness relatively more demand in the coming years. However, compounding drugs are not the only option for veterinarians to treat animals that need pro-kinetic drug therapy. The U.S. FDA highlights few critical animal shortages that include 35% Perox Aid, Epinephrine and Flunixine Injectable. The global animal drug compounding market is expected to witness a growth of 6.3% CAGR over the forecast period, 2016-2024. Market Dynamic Increasing availability and preference for flavored dosages will fuel demand for animal drug compounding in the coming years. In addition, for convenience in consumption, the veterinary drug compounders are likely to offer medicines that taste less bitter, creamy, non-gritty and smooth. Such factors contribute majorly towards enhanced patient compliance, and is likely to impact growth of the global market positively in the coming years. Attributed ...

Proton Therapy Market Predicted to Reach US$ 3,000 Million by the end of 2024

Increasing prevalence of cancer is compelling healthcare organizations to adopt and develop more advanced treatment processes. In recent years, proton radiotherapy has emerged as one of the most effective cancer treatment in the world. Owing to its overwhelming success, the particular therapy has gained healthy popularity amongst doctors and patients all over the world. In most cases, the therapy gives positive results in destroying tumor cells by eliminating their DNA using high-intensity radiation dosage that is deposited on the target. In addition, medical professionals having specialization in cancer treatment prefer and recommend proton therapy owing to its feasibility and compatibility with other treatments. Such aforementioned factors are promoting the adoption of proton therapy treating carcinogenic abnormalities. According to the latest data released by Persistence Market Research (PMR), the global proton therapy market will garner over US$ 2,926.7 Million in revenues b...